The Market Reports

Synopsis
The global market for Animal Model for Testing was estimated to be worth US$ 2609 million in 2024 and is forecast to a readjusted size of US$ 3750 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process. Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans. In our report, all the animals used in scientific purposes are included.
The Animal Model for Testing market is driven by the increasing demand for reliable preclinical data in drug development, biomedical research, and regulatory approval processes. As pharmaceutical and biotechnology companies expand their R&D pipelines, animal models remain essential for evaluating disease mechanisms, therapeutic efficacy, and drug safety before human clinical trials. The rise in chronic and rare diseases, along with advancements in genetic engineering technologies, has led to the development of more precise and disease-specific animal models. Additionally, supportive government funding and collaborations between academia and industry are accelerating the adoption of advanced animal models, particularly in oncology, neurology, and infectious disease research.
Despite their critical role, animal models for testing face several significant challenges, particularly ethical concerns and scientific limitations. Growing pressure from animal welfare organizations and stricter regulatory guidelines are increasing scrutiny around the use of animals in research. Moreover, the high cost and complexity of developing and maintaining genetically modified or disease-specific models limit their accessibility, especially for smaller institutions. Scientific limitations also persist, as animal models do not always accurately predict human responses, leading to potential setbacks in drug development. These challenges are driving the push toward alternative testing methods, such as in vitro systems and computer-based simulations, though these are not yet fully capable of replacing animal models in all research contexts.
Global Animal Model for Testing key players include Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, etc. Global top four manufacturers hold a share about 45%. North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share over 50 percent. In terms of product, Mice is the largest segment, with a share over 60%. And in terms of application, the largest application is Pharmaceutical and Biotechnology Companies, followed by Academic and Research Institutes.
This report aims to provide a comprehensive presentation of the global market for Animal Model for Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Animal Model for Testing by region & country, by Type, and by Application.
The Animal Model for Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Model for Testing.
Market Segmentation
By Company
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Vitalstar Biotechnology
JANVIER LABS
Segment by Type
Rats
Mice
Others
Segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Animal Model for Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Animal Model for Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Animal Model for Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index